In papillary thyroid cancer, low expression of FTO upregulates m6A methylation of apolipoprotein E (APOE) mRNA, modulating the IL-6/JAK2/STAT3 pathway, thus promoting tumor glycolysis and growth [184]. Here, APOE is linked to thyroid gland papillary carcinoma.